Natalia Baran, Adjunct Associate Professor at The University of South Dakota, shared on LinkedIn:
“It was a pleasure to welcome everyone, share insights into treatment options for relapsed/refractory multiple myeloma (RRMM) in Switzerland, and co-moderate this meeting together with Dr. Bastien Grandjean. The evening brought together valuable perspectives on unmet clinical needs and the evolving treatment landscape for multiple myeloma.
A special highlight was the excellent presentation by Dr. Marc-Andrea Bärtsch from University Hospital of Heidelberg, who shared important insights into emerging clinical evidence and its implications for everyday clinical practice.
We were also privileged to hear from Prof. Yan Guex-Crosier of the University of Lausanne (UNIL), a renowned ophthalmologist and ocular immunology specialist at Hôpital ophtalmique Jules-Gonin in Lausanne, who provided an important ophthalmological perspective on patient care.
It was equally valuable to hear Dr. Bastien Grandjean share his real-world clinical experience and practical insights into the management of patients with relapsed/refractory multiple myeloma.
I particularly enjoyed the lively panel discussion and engaging Qamp. A session, which sparked thoughtful questions and a rich exchange of clinical perspectives.
Many thanks to all the speakers, faculty members, and participants for making this such a stimulating and enriching evening. A great start to what I hope will be a continued exchange and collaboration!”
You can also read: Myeloma Paper of the Day, October 21st, Suggested by Robert Orlowski
